Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Cardiovascular Research|February 9, 2021
G protein-coupled receptor kinase 5 (GRK5) contributes to impaired cardiac function and immune cell recruitment in post-ischemic heart failureClaudio de Lucia, Laurel A Grisanti, Giulia Borghetti, et al.
Optics Express|September 22, 2011
Waveguide grating mirror in a fully suspended 10 meter Fabry-Perot cavityDaniel Friedrich, Bryan W Barr, Frank Brückner, et al.
Optics Letters|July 19, 2011
Translational, rotational, and vibrational coupling into phase in diffractively coupled optical cavitiesB W Barr, M P Edgar, J Nelson, et al.
Arthritis and Rheumatism|November 11, 1999
Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosisP J Clements, W K Wong, E L Hurwitz, et al.
Arthritis and Rheumatism|June 12, 1999
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trialP J Clements, D E Furst, W K Wong, et al.
Rheumatology (Oxford, England)|June 27, 2001
Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trialD E Furst, P J Clements, W K Wong, et al.
Arthritis and Rheumatism|November 18, 2000
Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trialP J Clements, E L Hurwitz, W K Wong, et al.
Arthritis and Rheumatism|March 27, 2001
The Disability Index of the Health Assessment Questionnaire is a predictor and correlate of outcome in the high-dose versus low-dose penicillamine in systemic sclerosis trialP J Clements, W K Wong, E L Hurwitz, et al.
Biorxiv : the Preprint Server for Biology|January 13, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Science Advances|October 15, 2025
Hydralazine inhibits cysteamine dioxygenase to treat preeclampsia and senesce glioblastomaKyosuke Shishikura, Jiasong Li, Yiming Chen, et al.
Pageof 21